Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01429584 · ClinicalTrials.gov registry record · NA
The Effect of Interscalene Peripheral Nerve Block With 0.25% Bupivacaine vs 0.125% Bupivacaine on Lung Function
A NA study of Diaphragm Paralysis, sponsored by University of Utah.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT01429584 is a NA study of Diaphragm Paralysis that has completed, run by University of Utah. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT01429584, a NA study of Diaphragm Paralysis, has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
Peripheral nerve blocks are used to provide post-operative pain relief. Nerve blocks in the neck, in the interscalene area, provide pain relief after shoulder surgery but can cause temporary weakness or paralysis of the diaphragm. The investigators hypothesized that a lower concentration of bupivacaine would cause less weakness of the diaphragm but still provide good pain relief. Lung function and pain control was studied after interscalene peripheral nerve block with 20 milliliters of 0.25% bupivacaine or 0.125% bupivacaine.
Conditions Studied
Interventions
- DRUG interscalene nerve block with 0.25% bupivacaine
- DRUG interscalene block with 0.125% bupivacaine
Study Locations (1)
Utah
- University of Utah Orthopaedics Center - Salt Lake City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2008-05 |
| Est. Completion | 2010-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01429584
The ClinicalTrials.gov registry entry for NCT01429584 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Utah, which has 818 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diaphragm Paralysis appearing as the primary indexed condition, and to 2 interventions - of which interscalene nerve block with 0.25% bupivacaine is the first listed.
NCT01429584 reports 1 study location spanning 1 distinct geographic area - top geographies include Utah.
Frequently Asked Questions
What is clinical trial NCT01429584 about?
NCT01429584 is a clinical study titled "The Effect of Interscalene Peripheral Nerve Block With 0.25% Bupivacaine vs 0.125% Bupivacaine on Lung Function". Peripheral nerve blocks are used to provide post-operative pain relief. Nerve blocks in the neck, in the interscalene area, provide pain relief after shoulder surgery but can cause temporary weakness or paralysis of the diaphragm. The investigators hypothesized that a lower concentration of bupivaca...
What is the current status of trial NCT01429584?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2008-05. Estimated completion is 2010-02.
What conditions does trial NCT01429584 study?
This clinical trial studies the following conditions: Diaphragm Paralysis.
What interventions are being tested in trial NCT01429584?
The interventions under investigation include: interscalene nerve block with 0.25% bupivacaine (DRUG), interscalene block with 0.125% bupivacaine (DRUG).
Who is sponsoring clinical trial NCT01429584?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01429584 being conducted?
This trial has 1 study location across Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.